0002060755-26-000034.txt : 20260612 0002060755-26-000034.hdr.sgml : 20260612 20260612143202 ACCESSION NUMBER: 0002060755-26-000034 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260612 DATE AS OF CHANGE: 20260612 EFFECTIVENESS DATE: 20260612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Conexeu Sciences Inc. CENTRAL INDEX KEY: 0002066836 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-548921 FILM NUMBER: 261086060 BUSINESS ADDRESS: STREET 1: 50 WEST LIBERTY STREET, SUITE 880 CITY: RENO STATE: NV ZIP: 89501 BUSINESS PHONE: 604-315-4722 MAIL ADDRESS: STREET 1: 50 WEST LIBERTY STREET, SUITE 880 CITY: RENO STATE: NV ZIP: 89501 D/A 1 primary_doc.xml X0708 D/A LIVE 0002066836 Conexeu Sciences Inc. 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 424-333-5622 NEVADA None None Corporation true 2022 DAVID R BOGART 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director MILES HARRISON 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Executive Officer Director AARON FARBERG 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director STEPHEN D INOUYE 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Executive Officer CLAUDIA CHAVEZ-MUNOZ 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Executive Officer JEFF SHARPE 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director Z PAUL LORENC 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director SEBASTIAN PURCELL 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director BRIAN PILCHER 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Executive Officer Biotechnology Decline to Disclose 06b true 0002060755-25-000021 2025-06-05 true true true true false 0 2200 1700 500 Total Offering Amount equals the aggregate price of 1,200,000 shares at $0.001 per share, plus the aggregate exercise price of 1,000,000 warrants exercisable at $0.001 per share. 500,000 warrants currently remain unexercised. false 3 0 0 0 false Conexeu Sciences Inc. /s/ Stephen Inouye Stephen Inouye CFO 2026-06-10